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Solution equilibrium studies on Fe(III) complexes formed with imidazole-4-carbohydroxamic acid (Im-4-Cha),N-Me-imidazole-
4-carbohydroxamic acid (N-Me-Im-4-Cha), imidazole-4-acetohydroxamic acid (Im-4-Aha), and histidinehydroxamic acid
(Hisha) have been performed by using pH-potentiometry, UV-visible spectrophotometry, EPR, ESI-MS, and 1H-NMR methods.
All of the obtained results demonstrate that the imidazole moiety is able to play an important role very often in the interaction
with Fe(III), even if this metal ion prefers the hydroxamate chelates very much. If the imidazole moiety is in α-position to the
hydroxamic one (Im-4-Cha and N-Me-Im-4-Cha) its coordination to the metal ion is indicated unambiguously by our results.
Interestingly, parallel formation of (Nimidazole,O hydroxamate), and (Ohydroxamate,O hydroxamate) type chelates seems probable with N-Me-
Im-4-Cha. The imidazole is in β-position to the hydroxamic moiety in Im-4-Aha and an intermolecular noncovalent (mainly H-
bonding) interaction seems to organize the intermediate-protonated molecules in this system. Following the formation of mono-
and bishydroxamato mononuclear complexes, only EPR silent species exists in the Fe(III)-Hisha system above pH 4, what suggests
the rather signiﬁcant “assembler activity” of the imidazole (perhaps together with the ammonium moiety).
Copyright © 2007 Etelka Farkas et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
The best-known hydroxamic acids belong to the microbial
siderophores [1]. These molecules quite generally contain
threechelatingfunctionsandareresponsibleforselectiveup-
take and transport of Fe(III) into the cells in adequate con-
centration. Because of the long-term usage of desferrioxam-
ine B (DFB), ﬁrst of all for the treatment of thalassemic pa-
tients, perhaps this compound is the most famous represen-
tative of the hydroxamate-based siderophore family [2, 3].
Not only natural, but also synthetic hydroxamic acids are
eﬀective metal binding agents and their numerous biolog-
ical eﬀects (e.g., capability for inhibition of various metal-
loenzymes) are strongly connected to their metal complex-
ation [4, 5]. Although their Fe(III) complexes are the most
stable nearly in all cases, they are also capable of strong in-
teraction with numerous other metals [6]. Moreover, the
preference of Fe(III) over some 3d M(II) metals, like Cu(II)
or Ni(II), can decrease, or even disappear, if additional N-
donor(s) is (are) situated in the molecule with chelatable
position to the hydroxamate function [6–8]. This may hap-
pen, for example, with the hydroxamic derivatives of amino
acids and peptides, because they are able to form very sta-
ble (Namino/peptide,N hydroxamate)-chelated complexes with the
metal ions like Ni(II), or Cu(II) and, especially with Cu(II),
very high stability polynuclear complexes (metallacrowns)
involving both (O,O-hydroxamate and N,N-amine) types of
chelates can also be formed [9, 10]. On the other hand,
such molecules form only hydroxamate-type (O,O)-chelates
with Fe(III), and both the electron-withdrawing eﬀect of
the amino group and electronic repulsion between the NH+
3
group and the Fe(III) ion decrease the stability of the hy-
droxamate chelate [11]. Therefore, an aminohydroxamic
acid generally forms lower stability Fe(III) complexes com-
pared to a simple monohydroxamic acid [6]. Somewhat,
more stable mono- and biscomplexes are formed with aspar-
tic acid-β-hydroxamic acid and glutamic acid-γ-hydroxamic
acid, what was assigned to the tridentate coordination of
these ligands via their hydroxamate and carboxylate oxy-
gens, but the coordination of the carboxylate cannot hinder2 Bioinorganic Chemistry and Applications
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Scheme 1: Formulae of the studied ligands.
the coordination of a third hydroxamate chelate [6]. Unique
bonding mode [12] and electrochemical behavior [13]o f
the Fe(III)-histidinehydroxamate complexes were found by
the few previous results, because the dominant role of the
imidazole- and the amino-N donors and the less important
part of the hydroxamate-type (O,O)-coordination were sug-
gested. In fact, the imidazole moiety is a favored coordinat-
ing site by numerous metals [14], but this suppression of
the hydroxamate-type coordination in Fe(III)complexes is
quite surprising. In order to get additional information on
this problem, detailed investigation of the Fe(III) complexa-
tion with histidinehydroxamic acid was carried out; further-
more, Fe(III) complexes of some other imidazole contain-
ing hydroxamic acids (the formulae of the ligands are shown
in Scheme1) were studied by pH-potentiometry, UV-visible
spectrophotometry, NMR, EPR spectroscopic, and ESI-MS
spectrometric methods.
2. EXPERIMENTAL
2.1. Reagentsandstocksolutions
L-Hisha was of the highest purity commercially available
(Sigma) and used without further puriﬁcation. Imidazole-
4-acetohydroxamic acid hydrochloride, imidazole-4-carbo-
hydroxamic acid hydrochloride, and N-methyl-imidazole-4-
carbohydroxamic acid hydrochloride were prepared as re-
portedpreviously[15].Theexactconcentrationoftheligand
stock solutions was determined by Gran’s method [16].
Fe(III) stock solution was prepared by dissolving FeCl3
(Reanal) in dilute HCl (0.1M). The concentration of the
metal ion stock solution was determined by gravimetry, via
metal oxide.
2.2. Potentiometricandspectroscopicstudies
All the measurements were carried out at an ionic strength of
0.2M, which was set with KCl. The temperature was always
25.0±0.1◦C. Carbonate-free KOH solution (0.2M) was used
astitrant.HClstocksolutionwaspreparedfromcc.HCl.The
concentrationsoftheKOHandHClweredeterminedbypH-
potentiometric titrations using the Gran method [16].
A Radiometer pHM 84 with Metrohm combined elec-
trode (type 6.0234.110) was used for pH-potentiometric
measurements with Metrohm 715 Dosimat automatic bu-
rette. The electrode system was calibrated according to Irv-
ing et al. and the pH-metric readings could, therefore, be
converted into hydrogen concentration [17]. The water ion-
ization constant (pKW) determined in the present work is
13.76 ± 0.01. All the pH-potentiometric titrations were per-
formed over the pH range of 2 to 11, or were terminated if
precipitate was formed. The initial volume of the samples
were 3.00 or 10.00mL. The ligand concentration was 0.01–
0.003M in each system measured and the metal ion concen-
tration was varied in the range of 0.0002–0.003M, in order
t og e t1:1 ,1:2 ,1:3 ,1:5 ,a n d1:1 0m e t a li o nt ol i g -
and ratios in the samples. The samples were completely de-
oxygenated by bubbling puriﬁed argon for approximately 20
minutes before the measurements. The equilibrium calcula-
tions were performed by the PSEQUAD computer program
[18]. Since the measurable hydrolysis of the Fe(III) ion starts
atlowpH,thehydrolyticspecies,withtheirﬁxedequilibriumEtelka Farkas et al. 3
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Figure 1:pH∗ dependenceofthe 1HNMRchemicalshiftsrecorded
for Hisha, cligand = 3· 10−3 M.
constants, were always included in our equilibrium models
when the experimental data for the Fe(III)-hydroxamate sys-
temswereﬁtted.Thehydrolysismodelandthestabilityofthe
hydroxo-complexesformedwerefoundintheliterature[19].
In addition to the generally used pH-potentiometry, the
interaction between these hydroxamate-based ligands and
Fe(III) was also followed by UV-visible spectrophotome-
try and the well-known characteristic charge transfer band
was evaluated. The iron (III)-monohydroxamato complexes
have spectra with λmax at ca. 510nm (ε◦∼ 1000mol−1cm−1),
the bishydroxamato ones display λmax at ca. 470nm (ε◦∼
1800mol−1cm−1), while λmax of the tris-complexes is at ca.
425nm(ε◦∼2600mol−1cm−1)[20].Spectrophotometrywas
usedtoclarifythecomplexformationbelowpH2,wherepH-
metry could not be used. In these cases, measurements were
carried out on individual samples in which the 0.2MKCl was
partially or completely replaced by HCl and the pH values,
varyingintherangeca.0.7–1.4,werecalculatedfromtheHCl
content.
APerkinElmerLambda25oranAvantesﬁberopticspec-
trophotometerequippedwitha2mmprobeheadbyusing20
milliseconds integration time and an average of 25 spectra
were used to record the UV-visible spectra for the Fe(III)-
hydroxamate complexes in the range of 300–800nm at all
metal-to-ligandratiosstudiedwithpH-potentiometry,inthe
0.0005–0.004M metal ion concentration region.
Magnetic measurements were carried out by using the
Evans method on a Bruker Advance II 300MHz NMR spec-
trometer[21].CoaxialNMRtubeswereused,wheretheinset
contained the reference D2O solution with 2% of t-BuOH,
while the paramagnetic species, dissolved in D2O containing
2% of t-BuOH, was in the outher tube. The concentration
of the metal ion was 0.006M at 1 : 3 metal-to-ligand ratio.
All measurements were performed without inert salt (KCl)
added. pH∗ values, in the range of 2–10, were set up with
D2SO4 or NaOD. The pH∗ value is a direct reading in a D2O
solution of the “H2O-calibrated” pH meter. The pH∗ values
can be converted to pH values using the following equation:
pH = 0.930 pH∗ +0 . 4 0[ 22].
Table 1: Dissociation constants (pK)(a) for the investigated
imidazole-containing ligands, t = 25◦C, I = 0.2 M (KCl).
Ligands Im-4-Cha(b) N-Me-Im-4-Cha(b) Im-4-Aha(b) Hisha(c)
pK1 3.76 5.06 6.17 5.38(4)
pK2 8.82 8.57 9.05 7.11(3)
pK3 — — — 9.06(2)
(a)Standard deviations are shown in parenthesis.
(b)See [15].
(c)The values determined for Hisha in the present work are in good agree-
ment with the previously published data in [12].
Electrospray ionization time-of-ﬂight mass spectromet-
ric(ESI-TOFMS)analysiswascarriedoutforeachsystemon
a Bruker BIOTOF II ESI-TOF instrument by using 0.006M
ligand concentration at 1 : 3 metal-to-ligand ratio. The pH
values were set at the Fe(III)-Im-4-Cha, -N-Me-Im-4-Cha, -
Im-4-Aha and -Hisha: 3.4, 6.4, 8.2, and 7.5, respectively. The
solutions were introduced directly into the ESI source by a
syringe pump (Cole-Parmer Ins. Comp. type 74900.) at a
ﬂ o wr a t eo f2μL/min. The temperature of drying gas (N2)
was 100◦C. The pressure of the nebulizating gas (N2)w a s3 0
psi. Voltages applied at the capillary entrance, capillary exit
and the ﬁrst and the second skimmers were −4500V, 120V,
40V, and 30V, respectively. The spectra were accumulated
and recorded by a digitizer at a sampling rate of 2GHz. The
spectrometer was operated at unit mass resolution and was
calibrated to sodium triﬂuoroacetate.
Anisotropic X-band EPR spectra of frozen solutions
were recorded at 77K in 100–4500G region, using a
Bruker EleXsys E500 spectrometer after the addition of 10%
methanol to ensuregood glass formation. All the solutions
were ﬁltered before the measurements.
3. RESULTS AND DISCUSSION
3.1. Proton-dissociationequilibriaoftheligands
The totally protonated forms of the imidazole-hydroxamic
acidsIm-4-Cha,N-Me-Im-4-Cha,andIm-4-Ahainvolvetwo
dissociable protons each, so their general formula is H2L+.
There are clear evidences in our previous paper [15] that
in all of these molecules, the dissociation of the two pro-
tons occurs in almost completely separated processes and
the lower pK belongs to the dissociation of imidazole-NH+,
while the higher to the proton release from the hydroxamic
moiety. Based on the exceptionally low pKa1 of Im-4-Cha,
theexistenceofhydrogenbondbetweentheimidazole-Nand
hydroxamic-NH was suggested [15]. The dissociation con-
stants taken from 14 are shown in Table 1.
In contrast to the situation of the above three imida-
zole derivatives, the dissociation of the protons from the
completely protonated Hisha (H3L2+) occurs in overlapping
processes, what is well demonstrated by the pH-dependence
of the chemical shifts of the nonlabile protons (Figure 1).
As a consequence, pK values shown in Table 1 are macro-
constants, characterize the proton releasing at molecular
level, but cannot be designated to the individual moieties.4 Bioinorganic Chemistry and Applications
Table 2: Overall stability constants for the complexes formed in
the Fe(III)-Im-4-Cha, Fe(III)-N-Me-Im-4-Cha and Fe(III)-Im-4-
Aha systems∗ I = 0.2M (KCl), t = 25◦C.
Ligands Im-4-Cha N-Me-Im-4-Cha Im-4-Aha
[FeLH]3+ 12.1(2) 13.95(3) 15.62(2)
[FeL]2+ 10.46(1) 11.92(4) —
[FeL2H2]3+ — — 30.11(2)
[FeL2]+ 18.65(4) 23.04(4) —
[FeL2H−1] — 18.8(1) —
[FeL3H3]3+ — — 43.47(6)
[FeL3H2]2+ — — 38.17(4)
[FeL3H]+ — — 31.99(5)
FeL3 — 31.3(2) 24.97(5)
∗Standard deviations are shown in parenthesis.
However, it is clearly shown by Figure 1 that out of the three
groups, the imidazole-NH+ is the most acidic.
3.2. Fe(III)complexesoftheligands
ComplexeswithIm-4-Cha,N-Me-Im-4-Cha,andIm-4-Aha
In these molecules, the donor atoms are the imidazole-
nitrogen, the hydroxamate oxygens, and (except N-Me-Im-
4-Cha, where this donor is not available) the hydroxamate
nitrogen. The most possible chelation modes between these
ligands and a metal ion are summarized in Scheme 2.
It is beyond doubt that, most of all, the coordination
mode (a) can be expected with Fe(III). Conditional stability
of (b) is much lower than (a) even with less hard metal ions
than Fe(III) [15], so its formation is not probable here. The
mode (d) is excluded with N-Me-Im-4-Cha, while the mode
(c) would result in the formation of a low-stability seven-
membered chelate with Im-4-Aha. It is easy to understand
that (b) and (c) cannot be formed at the same time with the
samemolecule,whilepolynuclearcomplexesareexpectedvia
parallel formation of (a) and (d). Following this theoretical
speculation, the obtained results are summarized below.
With Im-4-Cha precipitation occurred at pH 3-4 in pres-
ence of Fe(III) (this is the reason why the titration curves are
interrupted in Figure 2), therefore only a few species could
be detected before precipitation.
The equilibrium model yielding the best ﬁt of the titra-
tion curves together with the overall stability constants is
shown in Table 2.
A comparison of the corresponding constants of the
complexes of Im-4-Cha with those of a simple monohydrox-
amic acid, such as acetohydroxamic acid, CH3CONHOH
(log βFeL = 11.09, log βFeL2 = 20.69 [20]), supports the pre-
dominance of the hydroxamate-type coordination mode in
the water-soluble Fe(III)-Im-4-Cha complexes. The same
conclusion can be drawn from UV-visible spectra detected
at diﬀerent ratios (some of them are presented in the inset in
Figure 2). The charge transfer band indicates appearance of
(O,O)-hydroxamate-Fe(III) interaction above ca pH 1. The
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Figure 3: pH-potentiometric titration curves registered for N-Me-
Im-4-Cha (1) and Fe(III)-N-Me-Im-4-Cha systems at metal-to-
ligand ratio 1 : 5 (2) ,1:3( 3), 1 : 2 (4)a n d1:1( 5). Inset: selected
UV-VIS spectra registered for the Fe(III)-Im-4-Cha as a function of
pH at 1 to 5 metal-to-ligand ratio cligand = 3 · 10−3 M.
formation of the monochelated complex (λmax = 510nm)
is completed by pH ca. 2.5 (this depends somewhat on the
metal-to-ligand ratio) and bischelated complex(es) (λmax =
470nm) could also be detected before the precipitation. Due
totheverylowbasicityoftheimidazole-N,formationofpro-
tonated complexes is not really favored with this ligand and,
as a consequence, [FeLH]3+ is the only one, what appears in
low concentration (max. 10%) at very low pH. The unex-
pectedly poor solubility of the complexes formed above pH
3-4 indicates involvement of the imidazole in the interaction
(Generally, even the neutral, tris-chelated Fe(III)-complexes
of small monohydroxamic acid molecules have good water
solubility.) (one possibility for this is presented in Scheme 3,
demonstrating formation of polynuclear complexes, which
might have low water solubility). Unfortunately, we still have
not been successful to get any direct information on the sto-
ichiometry and bonding mode of the solid-state complexes
formed.
Much more soluble complexes are formed with N-Me-
Im-4-Cha as it is demonstrated by Figure 3, what, moreover,Etelka Farkas et al. 5
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clearly shows metal-induced deprotonation of both the hy-
droxamic and imidazole-NH+ protons.
Fitting the experimental data resulted in the model
in Table 2. This model involves mono-, bis-, and tris-
complexes. Out of them, the latter two were also supported
b yE S I - M Sa t1:3r a t i o ,a tp H= 8.2 (characteristic m/z val-
ues for the sodium salts are 359, 499). However, if the sta-
bility constants shown for the complexes in Table 2 are an-
alyzed, one can ﬁnd them somewhat higher than expected
for simple hydroxamate-type complexes (Scheme 2(a)). Just
for comparison, for N-Me-acetohydroxamic acid the pK =
8.70 and the overall stability constants are log βFeL = 11.85,
log βFeL2 = 21.58, while log βFeL3 = 29.36 [20]. Also the
minimum λmax v a l u e ,w h a tw o u l db ee x p e c t e di nt h er a n g e
of 425–430nm for a tris-hydroxamato complex, here is ca.
455nm (see inset in Figure 3). The most possible explana-
tion for all the above ﬁndings is that not only one type of
bonding modes belongs to the complexes with the same stoi-
chiometry, but diﬀerent bonding isomers exist. For example,
[FeL]2+ may involve either hydroxamate (O,O)-type chelate
(Scheme 2(a)) or (Nimidazole,O hydroxamate)-type one (Scheme
2(c)). This situation was previously suggested between N-
Me-hydroxamic acids and several metal ions [15]. Existence
of mixed type chelated complexes is suggested in the bis- and
tris-complexes.
Im-4-Aha involves the imidazole moiety in β-position to
the hydroxamic one. The pH-metric titration curves for the
Fe(III)-Im-4-Ahasamplesarepresentedtogetherwiththatof
the free ligand in Figure 4.
Figure 4 shows that if there is enough ligand excess,
there is no precipitation up to pH ca. 8–10 (curves 2 and
3) in the samples, but if not, hydroxo species precipitate
at pH ca. 4, or somewhat below. It is also clear that the
imidazole-NH+, which dissociates in the free ligand in the
pH-range 5–7 (Figure 4, curve 1), is released almost in the
same range from the Fe(III)-complexes (curves 2 and 3). It6 Bioinorganic Chemistry and Applications
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Figure 5: Representative concentration distribution curves calculated for Fe(III)-Im-4-Aha system at 1 to 3 metal-to-ligand ratio, showing
also pH dependence of the diﬀerences between the 1H NMR chemical shifts (Δδ values) of t-BuOH in dia- and paramagnetic surroundings
at the same metal-to-ligand ratio (dashed line) (a), and EPR spectra registered for Fe(III)-Im-4-Aha system at 1 to 3 metal-to-ligand ratio at
diﬀerent pH values (b), T = 77K; cligand = 3 · 10−3 M.
Table 3: Overall stability constants for the complexes formed in the
Fe(III)-Hisha system∗; I = 0.2 M(KCl), t = 25◦C.
Species log β
[FeLH2]4+ 21.98(6)
[Fe(LH2)2]5+ 43.45(3)
[FeL2H3]4+ 38.11(7)
[Fe(LH2)]3+ 32.59(5)
[FeL2H]2+ 25.81(9)
[FeL2]+ 19.53(5)
[FeL2H−1] 12.05(5)
Number of points ﬁtted 292
Fitting (cm3)8 . 4 ·10−3
∗Standard deviations are shown in parenthesis.
means that this proton is not displaced by the metal ion,
consequently, the imidazole-N of Im-4-Aha does not co-
ordinate to the Fe(III) ion. In accordance with these ﬁnd-
ings, the equilibrium model involves large amount of pro-
tonated complexes, in which the imidazole-N still contains
the proton (see Table 2) and only hydroxamate type coor-
dination of the ligands occurs. The UV-visible results agree
completely with this suggestion (see Inset in Figure 4), but
there is some doubt if we look at the EPR and magnetic mo-
ment results. To demonstrate this, together with the concen-
tration distribution curves at 1 : 3 metal-to-ligand ratio, dif-
ferences between the chemical shifts of t-BuOH in dia- and
paramagnetic surroundings as a function of pH are shown
in Figure 5(a). (Mass magnetic susceptibilities calculated by
the Evans method from these NMR data [21] show com-
pletely the same proﬁle, therefore are not presented here.)
Figure 5(b) shows the EPR spectra recorded at various pH.
Figures 5(a) and 5(b) show that there is some decrease
both in the NMR Δδ values and in the intensity of the EPR
signal within the pH range ca. 5–7, where ﬁrst of all the
[FeL3H2]2+ and [FeL3H]+ complexes dominate. Possible ex-
planation of these results is that some intermolecular inter-
action(H-bond)betweenthealreadynonprotonatedandthe
still-protonatedimidazoleringsexists,resultinginsomecou-
pling between the paramagnetic metal centers.
ComplexeswithHisha
As it is shown in Scheme 1, in this ligand, the RN substituent
also involves an amino moiety in addition to the imidazole
function. A further diﬀerence is that the imidazole-N is sit-
uated in γ-position to the hydroxamic moiety (what is α in
the Im-4-Cha or N-Me-Im-4-Cha and β in the Im-4-Aha).
Due to these structural diﬀerences, the Fe(III)-binding be-
havior of Hisha is also diﬀerent from that of the above de-
tailed imidazole-hydroxamic acids. To demonstrate this dif-
ference, some of the registered UV-visible spectra as a func-
tion of pH are shown in Figure 6.
As Figure 6 shows, there is some complex formation
between Fe(III) and Hisha already at pH 2, and the
λmax at ca. 500nm suggests the presence of an Fe(III)-
monohydroxamato (Scheme 2(a)) species, but some bishy-
droxamato complex can also be present. At this pH, however,
and also in all the spectra registered below ca. pH 2.5–3, the
presence of some Fe(III)-chloro complexes can be detected
too (characteristic λmax ca. 340nm) [23]. With increasing
the pH from 2 to ca. 4, λmax shifts from 500nm to 470nm
and also the molar absorptivity increases, which suggests the
dominance of the bishydroxamato complex at the latter pH.
On increasing the pH further, dramatic change in the spec-
trum occurs (This change in the spectra was practically the
same at all the ratios studied, except 1 : 1, where precipitate
was formed above pH 3.5.). First, a signiﬁcant decrease in
the intensity can be observed, then the intensity of a broad-
band (superposition of two bands with λmax values 620 and
ca. 500nm) increases up to pH ca. 7. Above this pH, the peak
at 620nm decreases intensively, while the other shifts to the
lower wavelengths.
All the above ﬁndings (together with the only previous
results [12]) have been taken into account when the pH-
potentiometrictitrationcurveswereﬁtted.CalculationshaveEtelka Farkas et al. 7
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Figure 6: Selected UV-VIS spectra registered in the Fe(III)-Hisha
system as a function of pH at 1 to 10 metal-to-ligand ratio; cligand =
5·10−3 M.
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lated for Fe(III)-Hisha system at 1 to 3 metal-to-ligand ratio, on the
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NMR chemical shifts (Δδ values) of t-BuOH in dia- and paramag-
netic surroundings for Fe(III)-Hisha (dashed line) at 1 to 3 metal-
to-ligand ratio, cligand = 3 · 10−3 M.
been done with numerous reasonable models, including tris-
anddinuclearcomplexes,butunambiguously,thebestﬁtting
was obtained with the model shown in Table 3 (e.g., if tris-
complexes were also involved, the ﬁtting was 1.03 · 10−2 and
the standard deviations were unacceptably high). As a conse-
quence, the equilibrium model shown in Table 3 diﬀers from
thepreviouslypublishedone[12].Namely,tris-hydroxamato
c o m p l e x e sw e r en o tf o u n dt of o r mi nm e a s u r a b l ec o n c e n t r a -
tion under our conditions even at 1 : 10 metal-to-ligand ra-
tio(although,theshoulderatca.430nmbeingonthespectra
frompH5.91inFigure 6mightindicatethepresenceofsmall
amount of tris-complexes) (maximum 1 : 20 ratio was used
in [12], where measurable formation of tris-complexes was
found).
By using the accepted model and stability constants, con-
centration distribution curves were calculated and are pre-
sented in Figure 7.
According to our model (see Table 3 and Figure 7), the
complex formation starts with the appearance of [FeLH2]4+
in measurable concentration. Most probably, the hydroxa-
mate oxygens coordinate to the metal ion, while the amino
group and the imidazole-N are still protonated in this
species. The next complex [Fe(LH2)2]5+ is suggested to in-
volve the two ligands in the same (hydroxamate-type) co-
ordination mode. The stepwise deprotonation of this latter
complexstartsabovepHca.3.5–4and,parallel,theΔδ values
(namelythemagneticsusceptibility)aredecreasing.IftheΔδ
values,obtainedhere,arecomparedtothosemeasuredunder
the same condition for the Fe(III)-Im-4-Aha (Figure 5(a))
and Fe(III)-acetohydroxamic (Aha) systems, (Δδ values reg-
istered in this work for the Fe(III)-acetohydroxamic acid
sample at 1 : 3 ratio are 0.110 ± 0.005ppm in the pH-
range 2–9, and intensively starts to decrease above pH 9)
one can ﬁnd that much lower values belong to the Fe(III)-
Hisha system than to the Fe(III)-Im-4-Aha and especially to
the Fe(III)-Aha. The UV-visible spectra, as it was detailed
above (Figure 6), also show signiﬁcant changes. A compar-
ison of Figures 6 and 7 shows that the decrease of the ab-
sorbance starts, where the concentration of [Fe(LH2)2]5+
startstodecrease(parallel,theconcentrationof[Fe(L2H3)]4+
then [Fe(LH)2]3+ increases), where, based on the acidities,
ﬁrst of all the imidazole-NH+ moieties are assumed to de-
protonate. However, dramatic increase of the absorbance oc-
curs, where the coordinated ligands start to release their last
dissociable protons from the -NH+
3 groups.
The above ﬁndings, together with the EPR results, what
showedthatexclusivelyEPRsilentspeciesexistintheFe(III)-
Hisha system at 1 : 3 ratio above pH 4, indicate metal-metal
coupling in this pH-region. Since stepwise deprotonation of
[Fe(LH2)2]5+ is accompanied by the above detailed changes,
this suggests the involvement of the nonprotonated side-
chain donors (imidazole-N and, at higher pH, perhaps the
amino-N) in the coordination. Either coordinative or non-
covalent (H-bond, stacking) interaction of imidazole-N can
be assumed, which, at least in some extent, should be inter-
molecular (e.g., H-bond between the already nonprotonated
and still-protonated imidazoles, or between the imidazole-
N and ammonium-NH+
3 protons) resulting in some metal-
metal coupling. Most probably, these interactions are able to
hinder the acceptance of the third hydroxamate chelate by
the metal ion at lower pH (below pH ca. 7) in high extent.
At higher pH, the formation of mixed hydroxo species seems
the most possible. The existence of this latter species is also
supported by the ESI- MS results. Two diﬀerent iron-ligand-
containing species can be detected in the positive region in
the spectrum at pH 7.5 (m/z values 394 and 435). The ﬁrst
can be assigned unambiguously to [FeL2]+, while the second
perhaps to [FeL(LH)(OH)]Na+.
4. CONCLUDING REMARKS
All the above results summarized for the systems containing
Fe(III) ion and Im-4-Cha, N-Me-Im-4-Cha, Im-4-Aha, or
Hisha demonstrate that the imidazole moiety is able to play
an important role very often in the interaction with Fe(III),
even if this metal ion prefers the hydroxamate chelates very
much. Moreover, each of the studied ligands forms com-
plexes with diﬀerent bonding modes.
If the imidazole and hydroxamic moieties are in α-
position to each other (Im-4-Cha, or N-Me-Im-4-Cha), co-
ordinative bonding of the imidazole seems possible. This8 Bioinorganic Chemistry and Applications
results in the formation of various poorly soluble polynu-
clear species with Im-4-Cha, while the appearance of the in-
teresting Nimidazole,O hydroxamate chelate seems probable with
N-Me-Im-4-Cha.
In Im-4-Aha, the imidazole is in β-position to the hy-
droxamic moiety and seems to organize the intermediate-
protonated molecules in the solution via noncovalent (ﬁrst
of all H-bonding) interaction. This interaction otherwise
cannot hinder the coordination of up to three hydroxamate
chelates to an Fe(III) ion, if there is enough ligand excess in
the solution.
The situation is quite diﬀerent with Hisha, in which the
position of the imidazole-N is γ to the hydroxamic moiety
and there is also an amino group in the molecule. The for-
mation of this hydroxamate-type complex was not found in
measurable concentration under the investigated conditions
(up to 1 : 10 metal-to-ligand ratio). This suggests rather sig-
niﬁcant role of the imidazole (perhaps together with ammo-
nium) in the interaction.
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